{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:46Z","timestamp":1759333666899},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00105-005-0921-x","type":"journal-article","created":{"date-parts":[[2005,3,4]],"date-time":"2005-03-04T12:11:49Z","timestamp":1109938309000},"page":"368-369","source":"Crossref","is-referenced-by-count":3,"title":["Topische Behandlung des subakut-kutanen Lupus erythematodes mit Tacrolimus"],"prefix":"10.1007","volume":"56","author":[{"given":"S.","family":"Meller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bruch-Gerharz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Homey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000074119","volume":"207","author":"Bohm","year":"2003","unstructured":"Bohm M, Gaubitz M, Luger TA et al. (2003) Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases. Dermatology 207:381?385","journal-title":"Dermatology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1038\/jid.1993.16","volume":"100","author":"David-Bajar","year":"1993","unstructured":"David-Bajar KM (1993) Subacute cutaneous lupus erythematosus. J Invest Dermatol 100:2S?8S","journal-title":"J Invest Dermatol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/00015550310007698","volume":"84","author":"De","year":"2004","unstructured":"De la Rosa Carrillo D, Christensen OB (2004) Treatment of chronic discoid lupus erythematosus with topical tacrolimus. Acta Derm Venereol 84:233?234","journal-title":"Acta Derm Venereol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09546630310017852","volume":"15","author":"Druke","year":"2004","unstructured":"Druke A, Gambichler T, Altmeyer P et al. (2004). 0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus. J Dermatolog Treat 15:63?64","journal-title":"J Dermatolog Treat"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2133.2003.05186.x","volume":"148","author":"Kanekura","year":"2003","unstructured":"Kanekura T, Yoshii N, Terasaki K et al. (2003) Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol 148:353?356","journal-title":"Br J Dermatol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keh325","volume":"43","author":"Lampropoulos","year":"2004","unstructured":"Lampropoulos CE, Sangle S, Harrison P et al. (2004) Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology 43:1383?1385","journal-title":"Rheumatology"},{"key":"CR7","first-page":"331","volume":"13","author":"Ruzicka","year":"2003","unstructured":"Ruzicka T, Assmann T, Lebwohl M (2003) Potential future dermatological indications for tacrolimus ointment. Eur J Dermatol 13:331?342","journal-title":"Eur J Dermatol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2133.2002.04875.x","volume":"147","author":"Schanz","year":"2002","unstructured":"Schanz S, Ulmer A, Rassner G, Fierlbeck G (2002) Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil. Br J Dermatol 147:174?178","journal-title":"Br J Dermatol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0025-7125(16)30620-4","volume":"73","author":"Sontheimer","year":"1989","unstructured":"Sontheimer RD (1989) Subacute cutaneous lupus erythematosus: a decade?s perspective. Med Clin North Am 73:1073?1090","journal-title":"Med Clin North Am"},{"key":"CR10","first-page":"50","volume":"12","author":"Yoshimasu","year":"2002","unstructured":"Yoshimasu T, Ohtani T, Sakamoto T et al. (2002) Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 12:50?52","journal-title":"Eur J Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-0921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-005-0921-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-0921-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:05Z","timestamp":1558582625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-005-0921-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1007\/s00105-005-0921-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}